The Institutional Biosafety Committee (IBC) is a standing committee and is responsible for reviewing all University research and teaching activities conducted by faculty, staff, students and/or visiting scientists on University property that involve the use of biological agents. Biological agents are defined as microorganisms, Recombinant or Synthetic Nucleic Acid Molecules experiments as defined by NIH Guidelines, materials derived from human and non-human primates, or biological toxins.
The mission of the IBC is to ensure that all activities involving biological agents and the facilities used to conduct such work are in compliance with all external regulations, and applicable University policies.
The committee will function to ensure that investigators handle biological agents in a safe and responsible manner, and meet criteria as described by the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules; the CDC/NIH publication Biosafety in the Microbiological and Biomedical Laboratories; applicable regulations defined by the Virginia Department of Environmental Quality; the OSHA Bloodborne Pathogens Standard; HHS and USDA final rules for the possession, use, and transfer of select agents and toxins; and other applicable requirements. Foremost, the IBC's objective shall be to ensure that such activities meet the standards of good biological safety practice emphasizing protection of personnel, the public and the environment.
The IBC shall assist principal investigators and protocol directors in meeting their responsibilities; impose requirements; and review and approve policies, proposals, procedures, programs, and facilities pursuant to the safe and legally compliant use of biological agents.
If you would like to attend a meeting, please contact Paul Skoglund at ps5d@virginia.edu or 434-243-0726, by the date the Registration Documents are due.
| Date of IBC Meeting | Date Registration (IAR) Documents are due |
|---|---|
| January 4th, 2024 (Thursday) | December 18th, 2023 |
| February 6th, 2024 | January 24th, 2024 |
| March 5th, 2024 | February 21st, 2024 |
| April 2nd, 2024 | March 22nd, 2024 |
| May 7th, 2024 | April 24th, 2024 |
| June 4th, 2024 | May 22nd, 2024 |
| July 2nd, 2024 | June 18th, 2024 |
| August 6th, 2024 | July 24th, 2024 |
| September 3rd, 2024 | August 21st, 2024 |
| October 1st, 2024 | September 18th, 2024 |
| November 7th, 2024 (Thursday) | October 23rd, 2024 |
| December 3rd, 2024 | November 19th, 2024 |
| January 7th, 2025 | December 17th, 2024 |
Prof. Glynis L. Kolling
IBC Chair
Research Associate Professor
Department of Biomedical Engineering
434-982-6267
Stacy Agar
IBC Member
Community Member
512-583-2485
Prof. Matthew Crawford
IBC Member
Research Assistant Professor
Department of Infectious Disease
434-924-5267
Marie Burdick
IBC Member
Principal Scientist
Department of Medicine, Pulmonary and Critical Care
434-243-7363
Sam Driver
IBC Member
Community Member
434-973-4333
Jennifer Kershner
UVA Biosafety Officer
Alternate Responsible Official (Select Agents)
434.982.4911
Tom Leonard
IBC Member
Responsible Official (Select Agents)
Director - Environmental Health & Safety
434.982.4911
Raphael Malbrue
IBC Member
Director - Center for Comparative Medicine
434.924.5058
Prof. Aaron L. Mills
IBC Member
Professor
Department of Environmental Sciences
434-924-0564
Prof. Brett Moreau
IBC Member
Research Assistant Professor
Department of Infectious Disease
434-243-2764
Prof. Ira Schulman
IBC Member
Associate Professor
Department of Pharmacology
434-924-5682
Paul Skoglund
IBC Coordinator
434-243-0726
